...
首页> 外文期刊>Journal of the American Chemical Society >Enantio- and Diastereodivergent Construction of 1,3-Nonadjacent Stereocenters Bearing Axial and Central Chirality through Synergistic Pd/Cu Catalysis
【24h】

Enantio- and Diastereodivergent Construction of 1,3-Nonadjacent Stereocenters Bearing Axial and Central Chirality through Synergistic Pd/Cu Catalysis

机译:通过协同PD / Cu催化,1,3-非加入立体中心的抗映射构造1,3-非静脉闭塞器轴承轴承轴承轴承

获取原文
获取原文并翻译 | 示例
           

摘要

In contrast to the widely explored methods for the asymmetric synthesis of molecules bearing a single stereocenter or adjacent stereocenters, the concurrent construction of 1,3-stereogenic centers in an enantio- and diastereoselective manner remains a challenge, especially in acyclic systems. Herein, we report an enantio- and diastereodivergent construction of 1,3-nonadjacent stereocenters bearing allenyl axial and central chirality through synergistic Pd/Cu-catalyzed dynamic kinetic asymmetric allenylation with racemic allenylic esters. The protocol is suitable for a wide range of substrates including the challenging allenylic esters with less sterically bulky substituents and provided chiral allenylic products bearing 1,3-nonadjacent stereocenters with high levels of enantio- and diastereoselectivities (up to >20:1 dr and >99% ee). Furthermore, several representative transformations involving axial-to-central chirality transfer were conducted, affording useful structural motifs containing nonadjacent stereocenters in a diastereodivergent manner.
机译:相反,与载有单个立体封闭物或相邻立体封闭的分子的不对称合成的广泛探索的方法相比,在肾上腺和非对映选择的方式中的1,3-立方根中心的同时构建仍然是一种挑战,特别是在无循环系统中。在此,通过协同PD / Cu催化的动态动态动力学非对称亚苯烷化与外烯基酯,报告亚苯基轴向和中枢性带有亚苯基轴向和中枢性性循环的抗体和歧视性构建。该方案适用于各种底物,包括具有较少的具有较少的巨大取代基的挑战性亚苯基酯,并提供具有高水平的肾上腺和非对映射性的手性亚烯酰基产物,含有1,3-非邻居的立体封闭物(高达> 20:1博士和> 99%EE)。此外,进行了涉及轴向 - 中枢性手性转移的几个代表性转化,得到了含有非映射的方式的有用的结构基序,其含有非静止的方式。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2021年第32期|12622-12632|共11页
  • 作者单位

    Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs Frontiers Science Center for Transformative Molecules School of Chemistry and Chemical Engineering Shanghai Jiao Tong University Shanghai 200240 China;

    Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs Frontiers Science Center for Transformative Molecules School of Chemistry and Chemical Engineering Shanghai Jiao Tong University Shanghai 200240 China;

    State Key Laboratory of Organometallic Chemistry Shanghai Institute of Organic Chemistry University of Chinese Academy of Sciences Shanghai 200032 China;

    Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs Frontiers Science Center for Transformative Molecules School of Chemistry and Chemical Engineering Shanghai Jiao Tong University Shanghai 200240 China;

    State Key Laboratory of Organometallic Chemistry Shanghai Institute of Organic Chemistry University of Chinese Academy of Sciences Shanghai 200032 China Research Centre for Molecular Recognition and Synthesis Department of Chemistry Fudan University Shanghai 200433 China;

    Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs Frontiers Science Center for Transformative Molecules School of Chemistry and Chemical Engineering Shanghai Jiao Tong University Shanghai 200240 China;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号